Is INSP stock a Buy, Sell, or Hold?

Based on our analysis, INSP is currently a HOLD with moderate confidence. 📊 HOLD: INSP shows mixed signals. Fine to hold existing positions. Not urgent to buy or sell.

What is the fair value of INSP stock?

Our analysis estimates the fair value range for INSP to be between $87.16 and $98.41. The current price is $75.78.

What is the analyst price target for INSP?

The average Wall Street analyst price target for INSP is $130.20. This implies a potential upside of 65.8% from current levels.

INSP Stock Analysis: Buy, Sell, or Hold?

INSP - Inspire Medical Systems, Inc.

SURGICAL & MEDICAL INSTRUMENTS & APPARATUS

$75.78

-2.76 (-3.51%) ▼

HOLD

MODERATE Confidence

Protect Your INSP Gains

Last Updated: January 30, 2026

Earnings: Feb 11, 2026 10d

Smart Money Accumulation

INSP is down 4.6% this week, but smart money is accumulating calls. Top strike: $85 2026-03-20 with 29 OI. Call ratio: 73% View Scanner →

Strength: 4.5/10

Get Alerted When INSP Hits Your Target Price

Join 10,000+ traders who never miss a move

You're in! Check your email to confirm and set your target price.

100% Free No spam, ever Unsubscribe anytime

Interactive Price Chart (1 Month)

Loading historical data...

💡

Bottom Line:
📊 HOLD: INSP shows mixed signals. Fine to hold existing positions. Not urgent to buy or sell.

Long-Term Wealth Forecast (2031)

Based on Analyst Consensus Growth & Historical Valuation

Adjust Growth Assumption: 7.5%

0% (Stagnation) 50% (Hyper Growth)

EST. PRICE IN 2031

$55.39

Based on 5.8% avg growth

INTRINSIC VALUE TODAY

$34.39

Trading above fair value

How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 25.0x Exit PE.

View Full DCF Model

In-depth Analysis How we analyze

Valuation Analysis: INSP is currently trading at $75.78, which is considered oversold relative to its 30-day fair value range of $87.16 to $98.41. From a valuation perspective, the stock is trading at a discount (Forward PE: 46.9) compared to its historical average (59.6). Remarkably, the market is currently pricing in an annual earnings decline of 7.7% over the next few years. This aligns with recent fundamental challenges.

Technical Outlook: Technically, INSP is in a uptrend. The price is currently testing key support at $74.99. A bounce from this level would confirm strength, while a break below could signal further downside. Short-term momentum is weak, with the stock down 3.5% recently.

Market Sentiment: INSP has a weak technical setup (25/100), with bearish trendlines and momentum suggesting caution for short-term entries. Wall Street analysts see significant upside, with an average price target of $130.20 (+65.8%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.

Quick Decision Summary

Current Position OVERSOLD

Fair Price Range $87.16 - $98.41

Company Quality Score 48/100 (HOLD)

Volume Confirmation HIGH

Confidence Score 52.4%

Protect Your Profits

Holding INSP? Use our AI-powered strategies to protect your downside while keeping your long-term position.

View Profit Protection Plan

All Signals

BULLISH: Price oversold vs 30-day range
BEARISH: Weak technical setup (25/100)
BULLISH: High volume confirmation
BEARISH: Downward momentum (-3.5%)
BULLISH: Trading 65.8% below Wall St target ($130.20)

Fair Price Analysis

30-Day Fair Range $87.16 - $98.41

Current vs Fair Value OVERSOLD

Support & Resistance Levels

Support Level $74.99

Resistance Level $97.52

Current Trend Uptrend

Fundamental Context

Forward P/E (Next Year Est.) 46.87

Wall Street Target $130.20 (+65.8%)

Revenue Growth (YoY) 10.5%

Earnings Growth (YoY) -43.6%

Profit Margin 5.1%

Valuation Discount vs History -7.7% cheaper

PE vs Historical 46.9 vs 59.6 CHEAP

Market-Implied Price Targets If current PE multiple persists

Implied Growth (YoY): -7.7% (market-implied from PE analysis)

1-Year Target $72.49 (-8%)

2-Year Target $66.91 (-15%)

3-Year Target $61.76 (-21%)

3-Yr Target (if PE normalizes) (PE: 47→60) $78.54 (0%)

3-Year Scenarios Using analyst projected EPS growth

Bull: (PE: 46.9, Growth: 7.5%) $97.68 (+24%)

Base: (SPY PE: 22.3, Growth: 7.5%) $46.48 (-41%)

Bear: (PE: 19.0, Growth: 7.5%) $39.51 (-50%)

📈 Valuation based on Current Earnings

RECOVERY PLAY: Stock looks expensive now (56x PE), but valuation improves significantly next year (47x PE) as earnings recover.

Trailing PE: 56.17 | Current EPS (TTM): $1.46

Bull Case $103.54 (+37%)

Analyst growth 14.8%, PE expands to 61.8

Base Case $94.13 (+24%)

Market implied 14.8%, PE stable at 56.2

Bear Case $55.77 (-26%)

Severe decline -20.0%, PE contracts to 47.8

These are projections based on PE multiples and EPS growth scenarios, not predictions. Actual results may vary significantly.

💡 Upside Surprise Potential

If earnings stabilize (0% growth), PE could expand from 46.9 to 59.6

Stabilization Target: $99.88 (+27.2%)

PE Expansion Potential: +27.2%

Last updated: January 30, 2026 11:32 PM ET
Data refreshes hourly during market hours. Next update: 12:32 AM

🔥 Top Stocks Breaking Out Now

Ticker	Score	Recommendation	Change %

See Full Scanner Results »

Technical Signals Check

Is INSP showing a specific setup today?

RSI Divergence Check TTM Squeeze Check MACD Crossover Check Gamma Walls Check Unusual Activity Check

Insider Activity (6 Months)

Buys

Sells

Net

INSIDERS SELLING

Recent Transactions

Richard Buchholz SELL 11000 shares 2025-08-29

View Insider Activity Scanner

Top Rated Medical Devices Stocks

Top-rated stocks in Medical Devices by analyst ratings.

Stock	Analyst Consensus	Analyst Target	Tradestie Score
BSX Boston Scientific Corp	STRONG BUY 34 analysts	$124	59 HOLD
SYK Stryker Corporation	BUY 32 analysts	$427	68 BUY
DXCM DexCom Inc	STRONG BUY 26 analysts	$85	65 BUY
ABT Abbott Laboratories	BUY 28 analysts	$136	63 BUY
MDT Medtronic PLC	BUY 32 analysts	$110	63 BUY

BSX Boston Scientific…

59 HOLD

SYK Stryker Corporati…

68 BUY

DXCM DexCom Inc

65 BUY

ABT Abbott Laboratori…

63 BUY

MDT Medtronic PLC

63 BUY

Advanced INSP Option Strategies

Professional options setups generated by AI based on today's INSP price and gamma walls.

Iron Condor Bull Call Bear Put Collar

More Analysis for INSP

INSP Technical Chart INSP Price Prediction INSP Earnings Date INSP Investment Advisor INSP Fair Price Analyzer INSP Options Advisor INSP Options Chain INSP Options Analysis INSP Competitors

Compare INSP with Other Stocks

Create New Comparison

Tradestie